Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+1.0%
5Y CAGR+8.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+1.0%/yr
vs +12.6%/yr prior
5Y CAGR
+8.6%/yr
Recent deceleration
Acceleration
-11.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$115.90M+2.5%
2024$113.06M+6.9%
2023$105.74M-6.0%
2022$112.45M+22.4%
2021$91.89M+20.0%
2020$76.60M+2.7%
2019$74.59M+6.6%
2018$70.00M+85.0%
2017$37.83M+80.9%
2016$20.91M-